Kallik has developed automated artwork solution software, enabling companies to better manage their labelling and packaging requirements. The company is focussed on sectors such as medical devices, pharmaceutical and chemicals where the risk of non-compliance with labelling regulation is an increasing focus of boardroom concern.
In August 2019, FPE Capital LLP completed the buyout of Kallik.
Midven’s Exceed Partnership was the sole institutional investor in Kallik and supported the company from 2013 to 2019. The sale realised a 3x cash multiple return and a 27% IRR.